• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估一种用于视神经脊髓炎血清学标准化的多参数免疫荧光分析方法。

Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology.

机构信息

Clinical Neurobiology Unit, Regional Referring Multiple Sclerosis Centre, University Hospital San Luigi Gonzaga, Orbassano, Turin, Italy.

出版信息

PLoS One. 2012;7(6):e38896. doi: 10.1371/journal.pone.0038896. Epub 2012 Jun 12.

DOI:10.1371/journal.pone.0038896
PMID:22719979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3373605/
Abstract

BACKGROUND

Neuromyelitis optica (NMO) is a severely disabling autoimmune disorder of the central nervous system, which predominantly affects the optic nerves and spinal cord. In a majority of cases, NMO is associated with antibodies to aquaporin-4 (AQP4) (termed NMO-IgG).

AIMS

In this study, we evaluated a new multiparametric indirect immunofluorescence (IIF) assay for NMO serology.

METHODS

Sera from 20 patients with NMO, 41 patients with multiple sclerosis (MS), 30 healthy subjects, and a commercial anti-AQP4 IgG antibody were tested in a commercial composite immunofluorescence assay ("Neurology Mosaic 17"; Euroimmun, Germany), consisting of five different diagnostic substrates (HEK cells transfected with AQP4, non-transfected HEK cells, primate cerebellum, cerebrum, and optic nerve tissue sections).

RESULTS

We identified AQP4 specific and non-specific fluorescence staining patterns and established positivity criteria. Based on these criteria, this kit yielded a high sensitivity (95%) and specificity (100%) for NMO and had a significant positive and negative likelihood ratio (LR+ = ∞, LR- = 0.05). Moreover, a 100% inter- and intra-laboratory reproducibility was found.

CONCLUSIONS

The biochip mosaic assay tested in this study is a powerful tool for NMO serology, fast to perform, highly sensitive and specific for NMO, reproducible, and suitable for inter-laboratory standardization as required for multi-centre clinical trials.

摘要

背景

视神经脊髓炎(NMO)是一种严重的中枢神经系统自身免疫性疾病,主要影响视神经和脊髓。在大多数情况下,NMO 与抗水通道蛋白-4(AQP4)的抗体(称为 NMO-IgG)相关。

目的

本研究评估了一种新的多参数间接免疫荧光(IIF)检测用于 NMO 血清学的方法。

方法

使用商业复合免疫荧光检测试剂盒(“神经科马赛克 17”;Euroimmun,德国),对 20 名 NMO 患者、41 名多发性硬化症(MS)患者、30 名健康对照者和一种商业 AQP4 特异性 IgG 抗体进行检测。该试剂盒由五种不同的诊断底物组成(转染 AQP4 的 HEK 细胞、未转染的 HEK 细胞、灵长类小脑、大脑和视神经组织切片)。

结果

我们确定了 AQP4 特异性和非特异性荧光染色模式,并建立了阳性标准。基于这些标准,该试剂盒对 NMO 具有高灵敏度(95%)和特异性(100%),且阳性和阴性似然比(LR+ = ∞,LR- = 0.05)显著。此外,还发现了该试剂盒具有良好的实验室间和实验室内重复性。

结论

本研究中测试的生物芯片马赛克检测试剂盒是一种用于 NMO 血清学的强大工具,操作快速,对 NMO 具有高灵敏度和特异性,重复性好,适合进行实验室间标准化,满足多中心临床试验的要求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ea/3373605/fe5d0934d7bf/pone.0038896.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ea/3373605/b192c033f4d8/pone.0038896.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ea/3373605/87118daf210b/pone.0038896.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ea/3373605/6ad756f7ecca/pone.0038896.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ea/3373605/fe5d0934d7bf/pone.0038896.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ea/3373605/b192c033f4d8/pone.0038896.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ea/3373605/87118daf210b/pone.0038896.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ea/3373605/6ad756f7ecca/pone.0038896.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ea/3373605/fe5d0934d7bf/pone.0038896.g004.jpg

相似文献

1
Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology.评估一种用于视神经脊髓炎血清学标准化的多参数免疫荧光分析方法。
PLoS One. 2012;7(6):e38896. doi: 10.1371/journal.pone.0038896. Epub 2012 Jun 12.
2
Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: comparison of tissue-based and cell-based indirect immunofluorescence assays and ELISA.视神经脊髓炎中水通道蛋白-4 抗体的检测:基于组织和基于细胞的间接免疫荧光测定和 ELISA 的比较。
J Clin Lab Anal. 2012 May;26(3):184-9. doi: 10.1002/jcla.21508.
3
Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica.视神经脊髓炎中抗人水通道蛋白4抗体新敏感检测方法的建立
Tohoku J Exp Med. 2006 Dec;210(4):307-13. doi: 10.1620/tjem.210.307.
4
Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders.视神经脊髓炎和相关疾病中抗水通道蛋白 4 的免疫球蛋白 M 抗体。
Clin Chem Lab Med. 2010 May;48(5):659-63. doi: 10.1515/CCLM.2010.127.
5
Clinical usefulness of cell-based indirect immunofluorescence assay for the detection of aquaporin-4 antibodies in neuromyelitis optica spectrum disorder.基于细胞的间接免疫荧光法检测视神经脊髓炎谱系疾病中水通道蛋白-4 抗体的临床应用。
Ann Lab Med. 2012 Sep;32(5):331-8. doi: 10.3343/alm.2012.32.5.331. Epub 2012 Aug 13.
6
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.抗水通道蛋白4抗体参与视神经脊髓炎的发病机制:抗体滴度研究
Brain. 2007 May;130(Pt 5):1235-43. doi: 10.1093/brain/awm062. Epub 2007 Apr 19.
7
Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.日本多发性硬化症中水通道蛋白4自身免疫性和脊髓病变的异质性
Brain. 2007 May;130(Pt 5):1206-23. doi: 10.1093/brain/awm027. Epub 2007 Apr 17.
8
Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience.视神经脊髓炎(NMO)中NMO-IgG抗体的血清阳性率及其在鉴别NMO与其他有重叠症状的脱髓鞘疾病中的特异性:一项伊朗的经验。
Iran J Allergy Asthma Immunol. 2015 Feb;14(1):98-104.
9
Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.视神经脊髓炎患者不同技术检测抗水通道蛋白 4 抗体。
Mult Scler. 2009 Oct;15(10):1153-63. doi: 10.1177/1352458509106851. Epub 2009 Aug 10.
10
Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.通过定量补体介导的对水通道蛋白4表达细胞的损伤来预测视神经脊髓炎发作的严重程度。
Arch Neurol. 2009 Sep;66(9):1164-7. doi: 10.1001/archneurol.2009.188.

引用本文的文献

1
Comparative Analysis of BIOCHIP Mosaic-Based Indirect Immunofluorescence with Enzyme-Linked Immunosorbent Assay for Diagnosing Myasthenia Gravis.基于生物芯片镶嵌的间接免疫荧光法与酶联免疫吸附测定法诊断重症肌无力的对比分析
Diagnostics (Basel). 2021 Nov 13;11(11):2098. doi: 10.3390/diagnostics11112098.
2
Transfection types, methods and strategies: a technical review.转染类型、方法及策略:技术综述
PeerJ. 2021 Apr 21;9:e11165. doi: 10.7717/peerj.11165. eCollection 2021.
3
A new M23-based ELISA assay for anti-aquaporin 4 autoantibodies: diagnostic accuracy and clinical correlation.

本文引用的文献

1
Failure of natalizumab to prevent relapses in neuromyelitis optica.那他珠单抗未能预防视神经脊髓炎复发。
Arch Neurol. 2012 Feb;69(2):239-45. doi: 10.1001/archneurol.2011.216.
2
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.视神经脊髓炎的血清学诊断:水通道蛋白 4-IgG 检测的多中心比较。
Neurology. 2012 Feb 28;78(9):665-71; discussion 669. doi: 10.1212/WNL.0b013e318248dec1. Epub 2012 Feb 1.
3
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder.
一种基于M23的抗水通道蛋白4自身抗体酶联免疫吸附测定法:诊断准确性及临床相关性
Auto Immun Highlights. 2019 Jun 19;10(1):5. doi: 10.1186/s13317-019-0115-7. eCollection 2019 Dec.
4
Spontaneous Improvement of Visual Acuity in a 13-Year-Old Boy with Neuromyelitis Optica Spectrum Disorder.一名患有视神经脊髓炎谱系障碍的13岁男孩视力的自发改善
Neuroophthalmology. 2018 Oct 29;43(2):114-119. doi: 10.1080/01658107.2018.1483951. eCollection 2019 Apr.
5
Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders.利妥昔单抗诱导视神经脊髓炎谱系障碍患者出现低丙种球蛋白血症。
Neurol Neuroimmunol Neuroinflamm. 2018 Sep 13;5(6):e498. doi: 10.1212/NXI.0000000000000498. eCollection 2018 Nov.
6
Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS.接受那他珠单抗治疗疑似多发性硬化症患者的水通道蛋白4抗体
Neurol Neuroimmunol Neuroinflamm. 2017 Jun 16;4(4):e363. doi: 10.1212/NXI.0000000000000363. eCollection 2017 Jul.
7
Mechanisms of Autoantibody-Induced Pathology.自身抗体诱导病理的机制。
Front Immunol. 2017 May 31;8:603. doi: 10.3389/fimmu.2017.00603. eCollection 2017.
8
Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study.利妥昔单抗治疗的视神经脊髓炎患者中水通道蛋白4抗体滴定:一项回顾性研究。
Neurol Neuroimmunol Neuroinflamm. 2016 Dec 15;4(2):e317. doi: 10.1212/NXI.0000000000000317. eCollection 2017 Mar.
9
Evaluation of aquaporin-4 antibody assays.水通道蛋白4抗体检测的评估
Clin Exp Neuroimmunol. 2014 Oct;5(3):290-303. doi: 10.1111/cen3.12107. Epub 2014 Apr 22.
10
Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology.通过筛查与确认相结合的下一代自身抗体检测——CytoBead®技术
Clin Rev Allergy Immunol. 2017 Aug;53(1):87-104. doi: 10.1007/s12016-016-8574-3.
视神经脊髓炎谱系疾病患者在接受芬戈莫德(FTY720)治疗后出现广泛脑部病变。
Mult Scler. 2012 Jan;18(1):113-5. doi: 10.1177/1352458511431973. Epub 2011 Dec 6.
4
Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature.视神经脊髓炎样疾病中抗CV2/CRMP5抗体:病例报告及文献综述
Clin Neurol Neurosurg. 2012 May;114(4):331-5. doi: 10.1016/j.clineuro.2011.10.048. Epub 2011 Dec 3.
5
Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4.酶联免疫吸附法用纯化的重组人水通道蛋白-4定量检测抗水通道蛋白-4 抗体。
Mult Scler. 2012 May;18(5):578-86. doi: 10.1177/1352458511424590. Epub 2011 Sep 30.
6
Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy.视神经脊髓炎尽管接受那他珠单抗治疗仍存在大量星形胶质细胞破坏。
Mult Scler. 2012 Jan;18(1):108-12. doi: 10.1177/1352458511421185. Epub 2011 Aug 25.
7
Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica.吗替麦考酚酯:视神经脊髓炎的耐受性、疗效和获益预测因素。
Neurology. 2011 Aug 16;77(7):659-66. doi: 10.1212/WNL.0b013e31822a2780. Epub 2011 Aug 3.
8
Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years.基于复发型视神经脊髓炎患者外周循环记忆B细胞评估进行利妥昔单抗重复治疗超过2年。
Arch Neurol. 2011 Nov;68(11):1412-20. doi: 10.1001/archneurol.2011.154. Epub 2011 Jul 11.
9
Impact of rituximab on relapse rate and disability in neuromyelitis optica.利妥昔单抗对视神经脊髓炎复发率和残疾的影响。
Mult Scler. 2011 Oct;17(10):1225-30. doi: 10.1177/1352458511404586. Epub 2011 May 26.
10
Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.风湿性疾病患者神经系统疾病中抗水通道蛋白-4 抗体的频率和综合征特异性。
Mult Scler. 2011 Sep;17(9):1067-73. doi: 10.1177/1352458511403958. Epub 2011 May 4.